Beijing, China

Binghua Xue

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Innovations in Diabetes Treatment by Binghua Xue

Introduction

Binghua Xue is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic diseases such as diabetes. With a total of two patents to his name, his work focuses on innovative methods that leverage gene-modified cells for therapeutic purposes.

Latest Patents

Binghua Xue's latest patents include a groundbreaking method of treating diabetes using FGF21 and GLP1 double gene-modified cells. This invention provides a modified mesenchymal stem cell and its culture supernatant, along with a pharmaceutical composition that includes these components. The mesenchymal stem cell is designed to express a first protein selected from FGF21 or its variants, and a second protein selected from GLP-1 or its variants. This innovative approach aims to enhance the treatment of metabolic diseases and facilitate the preparation of medicaments for such conditions.

Another notable patent by Xue is the FGF21 and GLP1 double gene-modified mesenchymal stem cell and its use in treating metabolic diseases. Similar to his previous patent, this invention also includes a modified mesenchymal stem cell and culture supernatant, emphasizing the potential of these cells in therapeutic applications.

Career Highlights

Binghua Xue is currently associated with Beijing Jiyuan Biological Technology Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for diabetes and other metabolic disorders.

Collaborations

Throughout his career, Binghua Xue has collaborated with notable colleagues, including Haifeng Duan and Jing Xie. These partnerships have contributed to the success of his innovative projects and the advancement of biotechnology in the medical field.

Conclusion

Binghua Xue's contributions to diabetes treatment through innovative gene-modified cell technologies highlight the potential of biotechnology in addressing metabolic diseases. His patents reflect a commitment to improving health outcomes and advancing scientific knowledge in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…